Please login to the form below

Not currently logged in
Email:
Password:

EMEA becomes EMA

The European Medicines Agency has officially launched a new organisational structure and visual identity, and will be known as the EMA from now on

The European Medicines Agency has officially launched a new organisational structure and visual identity, and will be known as the EMA from now on.

A key change to the structure is the integration of human pre- and post-authorisation activities into one unit, with the aim of guaranteeing a seamless lifecycle management of medicines. The creation of a new unit for patient health protection further strengthens the Agency's focus on safety monitoring of medicines. In addition, a dedicated group for the management of product data and documentation will improve the efficiency of data management processes throughout the Agency.

This is only the second major reorganisation of the Agency's services since it was established in 1995, and results from the expansion of the Agency's responsibilities and tasks, giving it a stronger role in the protection of public and animal health in Europe.

The number of medicines the Agency oversees has increased, as has the complexity of procedures. All of this has been underpinned by the creation of additional scientific committees and advisory groups, which require enhanced co-ordination and support. Legislative proposals currently being considered by the European Parliament and Council are expected to bring further responsibilities to the Agency.

Welcoming the changes, the Agency's executive director, Thomas Lönngren, said: "This package of changes aims at preparing the Agency for the future. The new structure reinforces our operational ability to deliver on our increasingly complex tasks, and our new visual identity will help to improve the quality and consistency of our communications with our partners and the public."

The new visual identity will help to promote public recognition of the Agency and its contribution to public and animal health.

The Agency's new public website is nearing the end of development and will be launched in the next few months. It will offer improved navigation and search functions. The Agency's website has changed to: www.ema.europa.eu

14th December 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics